目的:分析全身热疗联合化疗治疗中晚期非小细胞肺癌的临床应用研究.方法:在CENTRAL/Pub Med和中国生物医学文献数据库中检索1995年-2013年间比较全身热疗联合化疗治疗非小细胞肺癌的随机/对照临床研究,对符合标准的文献进行分析.结果:5篇文献(包括422例患者)符合入选标准,总缓解率分别为66.19%、24.68%,相对危险度(relative risk,RR)为1.59(95%CI:1.32-1.91),个体RR值波动于1.52-1.90之间.异质性检验未发现明显偏倚(P=0.99).结论:全身热疗联合化疗治疗中晚期非小细胞肺癌疗效优于单纯化疗.
Objective:To analyse clinical researches of whole body hyperthermia combined with chemotherapy inmiddle or advanced non small cell lung cancer.Methods:Randomized control clinical researches about whole bodyhyperthermia and chemotherapy in non small cell lung cancer during 1995-2013 were searched in CENTRAL/PubMed and Chinese Biomedical literature database.Literatures which matched with inclusion criteria were meta analysed.Results:5 articles (including 422 patients) were selected.Total remission rates of whole body hyperthermia and chemotherapy group were 66.19%,24.68%.Relative risk was 1.59 (95% CI:1.32-1.91).Individual RR fluctuate between 1.52-1.90.Heterogeneity test revealed no significant bias (P =0.99).Conclusion:The effect of whole body hyperthermia combined with chemotherapy in middle or advanced non small cell lung cancer was superior to chemotherapy.